- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Leading pharmaceutical companies: world market share 2010
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Leading pharmaceutical companies: world market share 2010
Market share of some leading pharmaceutical companies worldwide in 2010
This statistic shows the market share of some leading pharmaceutical companies worldwide in 2010. In that year, German pharmaceutical company Merck had a 0.8 percent share of the world market.
Market share of some leading pharmaceutical companies worldwide in 2010
| Market share | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Market share | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- June 2011
- Region
- Worldwide
- Survey time period
- 2010
Source
- Show sources information
- Show publisher information
- Release date
- June 2011
More information
- Region
- Worldwide
- Survey time period
- 2010
Other statistics on the topic
+Pharmaceutical Products & Market
Novartis' top drugs based on revenue 2018
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
+Pharmaceutical Products & Market
R&D spending share of top pharmaceutical companies 2018 and 2024
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate solution including all features.
Prices do not include sales tax.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
- Global positioning
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 pharmaceutical companies based on R&D spending as revenue share in 2018 and 2024*R&D spending share of top pharmaceutical companies 2018 and 2024
- Net profit per employee of global top 20 pharmaceutical companies in 2018 (in 1,000 U.S. dollars)Net profit generated per employee in top pharmaceutical companies 2018
- Company overview
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's net income from 2007 to 2018 (in billion U.S. dollars)Novartis' net income 2007-2018
- Dividends paid by Novartis AG from 2009 to 2018 (in billion U.S. dollars)Dividends paid by Novartis AG 2009-2018
- Total number of Novartis AG's full-time employees from 2009 to 2018*Novartis' number of full-time employees 2009-2018
- Revenue distribution
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Novartis AG's revenue from 2016 to 2018, by region (in million U.S. dollars)Novartis' revenue by region 2016-2018
- Percentage of Novartis AG's revenue in 2018, by segment and market*Novartis - revenue 2018 by segment and market
- Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2018*Percentage of Novartis pharmaceuticals revenue by therapy area 2018
- Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)Novartis' top drugs based on revenue 2018
- Research and development
- Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)Novartis' expenditure on research and development 2004-2018
- Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2018Novartis' R&D expenditure as a percent of revenue 2004-2018
- Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)Novartis' spending on research and development by division 2017-2018
- Miscellaneous
- Patients reached by products of Novartis AG from 2009 to 2018 (in millions)Patients reached by Novartis AG's products 2009-2018
- Novartis advertising spending in the United States from 2012 to 2018 (in million U.S. dollars)Novartis: ad spend in the U.S. 2012-2018
- Projected revenues of top global pharmaceutical companies 2012
- Top 10 - pharmaceutical companies based on revenue in 2006
- Journal spend of respiratory products in the U.S. 2016
- Top known pharma companies by Americans 2017
- Top known pharma companies by Americans and gender 2017
- Americans' preferred pharma companies for drug purchase, by gender 2017
- Brazil: leading pharmaceutical & cosmetics companies 2017, by revenue
- GAAP earnings - adjustments of selected U.S. pharmaceutical companies 2011
- Business risks at selected pharmaceutical companies 2011
- Lease expenses of selected U.S. pharmaceutical companies 2011 and 2016
- Quickness of financial reporting of selected pharmaceutical companies - U.S. 2012
- Journal spend of selected metabolic products in the U.S. 2016
- Italy: number of statements about pharmaceuticals 2019, by brand
- Corporate reputation of leading pharmaceutical companies in Spain in 2018
- Merck KGaA's number of employees 1999-2018
- Projected revenues of top global pharmaceutical companies 2012
- Top 10 - pharmaceutical companies based on revenue in 2006
- Journal spend of respiratory products in the U.S. 2016
- Top known pharma companies by Americans 2017
- Top known pharma companies by Americans and gender 2017
- Americans' preferred pharma companies for drug purchase, by gender 2017
- Brazil: leading pharmaceutical & cosmetics companies 2017, by revenue
- GAAP earnings - adjustments of selected U.S. pharmaceutical companies 2011
- Business risks at selected pharmaceutical companies 2011
- Lease expenses of selected U.S. pharmaceutical companies 2011 and 2016
- Quickness of financial reporting of selected pharmaceutical companies - U.S. 2012
- Journal spend of selected metabolic products in the U.S. 2016
- Italy: number of statements about pharmaceuticals 2019, by brand
- Corporate reputation of leading pharmaceutical companies in Spain in 2018
- Merck KGaA's number of employees 1999-2018
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
...and make my research life easier.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.